Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
TG Therapeutics, Inc. (TGTX) had Pre-Tax Income of $20.36M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$204.92M |
|
$19.78M |
|
$33.51M |
|
$171.41M |
|
$170.12M |
|
$34.80M |
|
$-14.43M |
|
|
Pre-Tax Income |
$20.36M |
$20.36M |
|
$19.78M |
|
$19.78M |
|
$19.78M |
|
$19.78M |
|
$34.80M |
|
$34.79M |
|
144.44M |
|
160.06M |
|
$0.14 |
|
$0.12 |
|
| Balance Sheet Financials | |
$1.09B |
|
-- |
|
$441.87M |
|
$1.53B |
|
$187.11M |
|
$745.14M |
|
$758.60M |
|
$945.71M |
|
$583.13M |
|
$583.13M |
|
$583.13M |
|
153.09M |
|
| Cash Flow Statement Financials | |
$-17.89M |
|
$-9.86M |
|
$390.83M |
|
$80.49M |
|
$443.56M |
|
$363.07M |
|
$19.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
0.56 |
|
1.28 |
|
83.65% |
|
16.98% |
|
16.98% |
|
-- |
|
9.94% |
|
9.65% |
|
$-17.95M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.26 |
|
0.52 |
|
172.19 |
|
3.39% |
|
3.39% |
|
1.29% |
|
1.49% |
|
$3.81 |
|
$-0.11 |
|
$-0.11 |
|